Quarterly report pursuant to Section 13 or 15(d)

CONDENSED BALANCE SHEETS

v2.4.0.8
CONDENSED BALANCE SHEETS (USD $)
Sep. 30, 2013
Dec. 31, 2012
Current Assets:    
Cash $ 165,907 $ 431
Accounts Receivable 1,661,733 0
Total current assets 1,827,640 431
Other Current Assets    
Prepaid Inventory 1,194,346 0
Inventory 2,394,419 0
Total Other Current Assets 3,588,765 0
Total Current Assets 5,416,405 431
Equipment, Net 199,060 0
Other Assets    
Intangible assets (net) 4,466,666 0
Investment in KannaLife 650,000 0
Total Other Assets 5,116,666 0
TOTAL ASSETS 10,732,131 431
Current Liabilities:    
Accounts payable 123,583 0
Accrued Interest 87,931 0
Equipment loan payable 30,000 0
Amount due to related party 300 500
Other Current Liabilities    
PhytoSPHERE Agreement 6,499,998 0
Total Current Liabilities 6,741,812 500
Long Term Liabilities    
Due to Roen Ventures, LLC 4,210,195 0
Total Long Term Liabilities 4,210,195 0
TOTAL LIABILITIES 10,952,007 500
STOCKHOLDERS' DEFICIT    
Common stock - par value $0.0001; 190,000,000 shares authorized; 11,741,667 and 7,000,000 shares issued and outstanding as of September 30, 2013 and December 31, 2012 respectively 1,174 700
Additional paid in capital 28,330,375 143,447
Accumulated Deficit (28,551,425) (144,216)
TOTAL STOCKHOLDERS' DEFICIT (219,876) (69)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT $ 10,732,131 $ 431